Atovaquone

25.00 - 50.00 INR

Get a Price/Quote

Product Details:

Molecular Weight 366.837 Grams (g)
Storage Room Temperature
Molecular Formula C22H19ClO3
Medicine Name Atovaquone
Type Pharmaceutical Intermediates
Grade Medicine Grade
Purity(%) 98%
Supply Ability : 1000 Kilograms Per Day
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Price And Quantity

Price Range 25.00 - 50.00 INR
Minimum Order Quantity 25 Kilograms

Product Specifications

Molecular Weight 366.837 Grams (g)
Storage Room Temperature
Grade Medicine Grade
Molecular Formula C22H19ClO3
Type Pharmaceutical Intermediates
Purity(%) 98%
Physical Form Powder
Medicine Name Atovaquone

Trade Information

Payment Terms Cash in Advance (CID), Cash Advance (CA)
Supply Ability 1000 Kilograms Per Day
Delivery Time 7 Days
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia

Product Description

It is a hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols. Our qualitative approach regarding the domain enabled us to merge as a trusted organization engaged in offering Atovaquone. This drug is used to prevent or treat a serious lung infection called Pneumocystis pneumonia. This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath. Atovaquone is a highly lipophilic drug that closely resembles the structure ubiquinone. This drug can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis.

Features:

Product Name : Atovaquone
Chemical Names : Mepron; Wellvone; Acuvel; Malarone Pediatric; Atovaquone & Interleukin 12
Molecular Formula : C₂₂H₁₉ClO₃
Molecular Weight : 366.841 g/mol
IUPAC Name : 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
CAS Number : 94015-53-9
Color : Crystals from acetonitrile
Melting Point : 216-219 Â°C
Solubility : Practically insoluble in water

Drug Indication: For the treatment or prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX).